Electroretinography Can Predict Diabetic Eye Disease Changes
The presentation reviews the capability of electroretinography to predict and evaluate retinal function.
Diabetic Retinopathy
Diabetic Retinopathy Study Suggests Reduced Prevalence in the United States
Approximately a quarter of those with diabetic retinopathy at baseline showed improvement.
Obesity Not Predictive of Diabetic Retinopathy Progression
The study also shows fewer patients with the condition are progressing than prior research indicated.
Aflibercept Cuts Vision-Threatening Complications of Diabetic Retinopathy
For eyes with NPDR, aflibercept injection is associated with a reduction in the proportion developing CI-DME with vision loss or high-risk proliferative diabetic retinopathy.
Study Outlines Components of Remote Diabetic Retinopathy Screening Success
Telemedicine programs need to close the “communication gap” between screening and diagnosis in diabetic eye disease.
OCT-A Scans Can Predict Worsening Diabetic Eye Disease
Monitoring changes at 2 retinal biomarkers, OCT-A can foretell visual outcomes and retinal sensitivity.
In Patients With T2D, Anemia Tied to Diabetic Retinopathy
In patients with type 2 diabetes mellitus, anemia is associated with the development of diabetic retinopathy.
The Importance of Regular Eye Screenings for Diabetic Retinopathy (Fact Sheet)
This fact sheet explains the importance of regular eye screenings to help detect and treat diabetic retinopathy.
Repeated Ranibizumab Injections Does Not Impair Macular Perfusion
For patients with diabetic macular edema, repeated ranibizumab treatment does not appear to be associated with impaired macular perfusion.
Prevalence of Persistent Diabetic Macular Edema: Bevacizumab vs Aflibercept or Ranibizumab
For patients with diabetic macular edema, persistence is more likely with bevacizumab than with aflibercept or ranibizumab.
- Loading...
Loading...
Next post in Diabetes
Loading... 
Loading...